Use of mGluR5 (esp. AFQ056) in GI (esp. GERD)

Details for Australian Patent Application No. 2006268905 (hide)

Owner Novartis AG

Inventors Gasparini, Fabrizio; Rouzade-Dominguez, Marie-Laure; Pfannkuche, HansJurgen

Agent Davies Collison Cave

Pub. Number AU-B-2006268905

PCT Pub. Number WO2007/006530

Priority 0514296.3 12.07.05 GB

Filing date 10 July 2006

Wipo publication date 18 January 2007

Acceptance publication date 21 January 2010

International Classifications

A61K 31/4045 (2006.01)

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/27 (2006.01)

A61K 31/4035 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/006530 Priority application(s): WO2007/006530

21 January 2010 Application Accepted

  Published as AU-B-2006268905

27 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268906-Metal salts of 2'-(1H-tetrazol-5-yl)-1.1'-biphenyl-4-car boxaldehyde

2006268899-Turbine for a hydroelectric power station